The discovery of ACVR1 as the gene responsible for FOP has opened the way to treatment discovery efforts, considering that the identification of a molecular target related to the disease is the very first step of a drug development process. The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.